In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects

NCT02521792 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped Subjects were enrolled into a different Phase 2 study (PVO-1A-202, NCT02279095).

Conditions

Interventions

Sponsor

Clementia Pharmaceuticals Inc.